The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab

Academic Article
Publication Date:
2023
Iris type:
01.08 Comunicazione in rivista (Letter - Letter to editor)
Keywords:
Paroxysmal nocturnal hemoglobinuria; Complement blockade; Complement C3; Complement C5; Intravascular haemolysis
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/447352
Published in:
BRITISH JOURNAL OF HAEMATOLOGY (PRINT)
Journal